<DOC>
	<DOCNO>NCT01464814</DOCNO>
	<brief_summary>The purpose study determine effect probiotic KE-99 Lactobacillus casei administer omega-3 fish oil probiotic viability , fecal make-up gastrointestinal ( GI ) health healthy adult .</brief_summary>
	<brief_title>Clinical Trial Evaluating Viability L. Casei + Fish Oil Capsules</brief_title>
	<detailed_description>This randomize , placebo control , crossover clinical trial determine effect KE-99 Lactobacillus casei omega-3 fish oil , probiotic purport promote beneficial effect gastrointestinal ( GI ) health . The study last approximately three week subject attend screen visit four follow-up visit . The study involve subject take probiotic product ( KE-99 + fish oil ) placebo , seven day ( per sponsor guidance ) , random order , seven day washout ( per sponsor guidance ) . Fecal analysis do begin end seven day supplementation period number live KE-99 feces determine high number positive ( indicate live KE-99 survive digestion ) . Although study population comprise generally healthy adult GI disorder symptom , sponsor hypothesizes may beneficial effect GI health KE-99 + fish oil supplementation . A six item questionnaire use ass change GI health ( e.g . abdominal pain , bloat gas ) low incidence indicate positive effect regard GI health .</detailed_description>
	<mesh_term>Signs Symptoms</mesh_term>
	<mesh_term>Signs Symptoms , Digestive</mesh_term>
	<criteria>Female subject surgically sterile , postmenopausal agrees use acceptable method birth control Subject able understand sign inform consent participate study Subject willing able comply protocol include : . Attending five visit ; b . Collecting four stool sample ; c. Refraining eat yogurt lactofermented beverage study ; d. Refraining use dietary supplement include probiotic prebiotics study ; e. Not take new vitamin and/or mineral supplement study completion . Subject follow medical condition : a. active heart disease , b. uncontrolled high blood pressure ( ≥ 140/90 mmHg ) , c. renal hepatic impairment/disease , d. Type I II diabetes , e. bipolar disorder f. Parkinson 's disease , g. unstable thyroid disease , h. immune disorder ( HIV/AIDS ) , i. psychiatric disorder ( hospitalize within past one year ) , j. medical condition deem exclusionary Principal Investigator ( PI ) Subject history cancer ( except localize skin cancer without metastasis situ cervical cancer ) within five year prior screen . Subject history currently gastrointestinal disease disorder inflammatory bowel condition Crohn 's disease , short bowel , ulcerative colitis , Irritable Bowel Syndrome ( IBS ) . Subject constipation define less three spontaneous bowel movement per week . Subject lactose intolerant ( selfprofessed diagnose ) . Subject stomach intestinal surgery ( i.e . gastric bypass ) . Subject take regular basis ( define two time per week ) prescription overthe counter medication diarrhea , constipation , heartburn gastrointestinal problem . Subject currently take laxative take laxative within 30 day prior screening/enrollment . Subject currently take antibiotic ( drug significantly interfere bacterial flora ) take antibiotic within 60 day prior screening/enrollment . Subject currently take use past 30 day probiotic ( include yogurt lactofermented beverage ) , prebiotic supplement , digestive enzyme [ prescription overthecounter ( OTC ) ] . Thirtyday washout allow . Subject unstable dose medication ( define few 90 day dose ) . Antihypertensives antihyperlipidemic medication ok stable dose . Subject currently take medication deem exclusionary PI . Subject exhibit evidence hepatic renal dysfunction evidence ALT , AST , AP ≥ two time upper limit normal serum creatinine value ≥ 2.0 mg/dl clinically significant abnormal clinical laboratory value per PI discretion . Subject allergy fish ingredient test product ( see section 3.2.1 ) . Subject history drug alcohol abuse past 12 month . Subject condition abnormality , opinion investigator , would compromise safety subject quality study data . Subject participate participate another research study within 30 day prior screen visit .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>probiotic</keyword>
	<keyword>fish oil</keyword>
	<keyword>digestion</keyword>
	<keyword>viability</keyword>
</DOC>